Connect with us

Hi, what are you looking for?

Daily Market SolutionDaily Market Solution

Investing

European shares rise 1% on tech boost; ECB meet in focus

By Pranav Kashyap

(Reuters) -European shares climbed 1% on Thursday, buoyed by strong performances among technology stocks, while investors awaited a policy decision from the European Central Bank later in the day where a rate cut is almost a certainty.

The pan-European STOXX 600 index was up 1% at 513.1 points, and set for the best day in more than one month, if gains hold.

All regional bourses were trading north of 1%.

Technology stocks chimed with a rally in their Asian peers, and jumped 2.5% to provide the biggest boost to the European benchmark index.

A Semafor report said the U.S. government is considering letting Nvidia (NASDAQ:NVDA) export advanced chips to Saudi Arabia, causing the AI-darling to surge 8%. [.N]

Basic resources gained 2.3% after prices of base metals rose, buoyed by hopes of an interest rate reduction in the U.S. next week. [MET/L].

All sub-sectors but one were trading in the green.

The European Central Bank (ECB) is set to convene at 1215 GMT, with widespread anticipation of a 25-basis-point rate reduction.

All eyes will be on ECB President Christine Lagarde’s remarks, due at 1245 GMT, as markets eagerly await confirmation on whether additional rate cuts are on the horizon for October and December.

“A rate cut today is fully baked in. The focus of the market is going to be when is the next ECB rate cut? We’re probably not going to get much guidance from that today,” said Ben Laidler, head of equity strategy at Bradesco BBI.

“I don’t think they need to do anything more aggressive. Clearly they could do though, if the data warranted it … the ECB is going to go slow and steady.”

Meanwhile, Spain’s consumer price figures showed the 12-month EU-harmonised inflation eased to 2.4% in August, causing the benchmark IBEX 35 index to gain more than 1%.

Swedish inflation eased 0.5% in August, just below forecast.

Shares of Roche fell 4% after the Swiss drugmaker said promising results of an early-stage trial of its experimental weight-loss pill were based on just six patients.

An overnight reading of U.S. core CPI showed that it rose 0.28% in August, slightly above a forecast rise of 0.2%, and that was enough for skittish markets to finally decide that the Federal Reserve will settle for a 25 bps rate cut next week.

This post appeared first on investing.com







    You May Also Like

    Editor's Pick

    Extremist supporters of former president Donald Trump are lashing out online against Usha Vance, the wife of Trump’s running mate, Sen. J.D. Vance (R-Ohio),...

    Investing

    Overview Energy Fuels (TSX:EFR,NYSE:UUUU) has been the largest producer of uranium in the United States and an emerging producer of rare earth elements (REEs)....

    Investing

    Investor Insight Silver prices breached $30/oz in the second half of May 2024 as investor demand drove prices to their highest in more than...

    Investing

    Overview Flynn Gold Limited (ASX: FG1) is an Australian mineral exploration company with a portfolio of projects in Tasmania and Western Australia. Tasmania is...

    Disclaimer: Dailymarketsolution.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2024 dailymarketsolution.com